Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 220051
Company: BPI LABS LLC
Company: BPI LABS LLC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SELENIOUS ACID | SELENIOUS ACID | 600UG/10ML | INJECTION | None (Tentative Approval) | None | No | No |
| SELENIOUS ACID | SELENIOUS ACID | 12UG/2ML | INJECTION | None (Tentative Approval) | None | No | No |
| SELENIOUS ACID | SELENIOUS ACID | 60UG/1ML | INJECTION | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/07/2026 | ORIG-1 | Tentative Approval | STANDARD |
Label is not available on this site. |